INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 3.35 billion | 6.7% | North America |
| by Product | by Procedure | by End User |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Interventional Oncology Market Overview
The global interventional oncology market is expected to grow at 6.7% CAGR from 2022 to 2029. It is expected to reach above USD 3.35 billion by 2029 from USD 1.9 billion in 2020.
Interventional oncology encompasses a spectrum of medical practices involving the diagnosis, treatment, and palliative care of cancer through minimally invasive procedures conducted under image guidance. The escalating incidence of cancer within the populace and the consequential strain on healthcare resources attributable to these ailments are anticipated to drive the demand for innovative interventional oncology methodologies and strategies for disease management.
For instance, in June 2023, data released by the U.S. Centers for Disease Control and Prevention (CDC) indicated 1,603,844 new cases of cancer and 602,347 cancer-related fatalities in the U.S. during 2020. Furthermore, an upsurge in cancer diagnoses and heightened research endeavors among industry stakeholders aimed at developing novel therapies for diverse cancer types are poised to catalyze growth in the global interventional oncology market throughout the forecast period.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion), (Thousand Units) |
| Segmentation | By Product, By Procedure, By Cancer, By End User, By Region |
| By Product |
|
| By Procedure |
|
| By Cancer |
|
| By End User |
|
| By Region |
|
Moreover, the global interventional oncology market witnessed a downturn in its growth trajectory owing to the COVID-19 pandemic. This decline was precipitated by governmental lockdown measures, leading to the postponement or cancellation of oncological treatments and subsequently reducing patient visits to hospitals and clinics. In recent years, there has been a notable surge in demand for minimally invasive procedures due to their inherent advantages over traditional treatment modalities.
Key benefits include diminished operative complications, shorter hospital stays, reduced postoperative discomfort, smaller incisions yielding cosmetic benefits, diminished infection risk, and expedited recovery periods. These procedures leverage advanced technologies for the diagnosis and treatment of various ailments, including cancer, offering a pragmatic means of tumor removal and lymph node extraction with minimal scarring. Additionally, minimally invasive techniques facilitate tissue biopsy and precise staging studies, augmenting diagnostic accuracy and treatment efficacy.
Interventional Oncology Market Segment Analysis
The Interventional Oncology market is divided on the basis of Product into Radiofrequency, Microwave, embolization, guidewires. Embolization devices will account for a portion of the interventional oncology market in 2020. Non-radioactive embolic agents and radioembolic agents are examples of embolic devices. Although these devices were originally developed to treat hepatocellular carcinoma, they have since been widely used to treat a variety of other cancers. These devices are utilised when ablation procedures cannot be used to treat tumours or when the tumour size is considerable. They’re also employed in palliative operations and as a pre-operative therapy to help with liver resection outcomes. On the basis of type of Procedure, it can be divided into Thermal, Non-Thermal Ablation, TACE, TARE, TAE. On the basis of cancer, this market is divided into liver, lung, kidney, bone metastasis. In 2020, liver cancer had the biggest proportion of the interventional oncology market. Interventional oncology is important in the treatment of liver cancer because surgical removal of the tumour may not leave the tissue healthy enough for the liver to function properly. Thus, interventional oncology techniques can successfully treat primary liver tumours or liver tumours caused by metastatic malignancies. As a result, interventional oncology is used in more than half of all primary and metastatic liver cancer therapies. On the basis of end-user, it can be categorized into hospital, ASC.
Interventional Oncology Market Players
Medtronic, Boston Scientific, BD, Terumo, Merit Medical, Angio Dynamics, J&J, Teleflex, Cook Medical, HealthTronics, MedWaves, Sanarus, IMBiotechnologies, Trod Medical, IceCure Medical, Mermaid Medicals, Interface Biomaterials BV, Guerbet, ABK Biomedical are the key players in the interventional oncology market.
Who Should Buy? Or Key Stakeholders
- Hospitals
- Clinics
- Government Healthcare organisations
- Government healthcare departments
- Information technology companies
- Others
Key Takeaways
- The global interventional oncology market is expected to grow at 6.7% CAGR.
- On the basis of Product, embolization devices will account for a portion of the interventional oncology market.
- On the basis of type of procedure, it can be divided into Thermal, Non-Thermal Ablation, TACE, TARE, TAE.
- On the basis of cancer, liver cancer had the biggest proportion of the interventional oncology market.
- North America dominated the market in the regional share.
- The integration of minimally invasive techniques like radiofrequency ablation and embolization therapies is a major trend in the interventional oncology market, offering precise tumor targeting and reduced patient recovery times.
Interventional Oncology Market Regional Analysis
The Interventional Oncology market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Key Market Segments: Interventional Oncology Market
Interventional Oncology Market by Product, 2020-2029, (USD Million)
- Radiofrequency
- Microwave
- Embolization
- Guidewires
Interventional Oncology Market by Procedure, 2020-2029, (USD Million)
- Thermal
- Non-Thermal Ablation
- TACE
- TARE
- TAE
Interventional Oncology Market by Cancer, 2020-2029, (USD Million)
- Liver
- Lung
- Kidney
- Bone Metastasis
Interventional Oncology Market by End User, 2020-2029, (USD Million)
- Hospital
- ASC
Interventional Oncology Market by Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important countries in all regions are covered.
Key Question Answered
- What is the current size of the Interventional Oncology market?
- What are the key factors influencing the growth of Interventional Oncology?
- What are the major applications for Interventional Oncology?
- Who are the major key players in the Interventional Oncology market?
- Which region will provide more business opportunities for Interventional Oncology in future?
- Which segment holds the maximum share of the Interventional Oncology market?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Interventional Oncology Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Global Interventional Oncology Market
- Global Interventional Oncology Market Outlook
- Global Interventional Oncology Market by Product, (USD Million)
- Radiofrequency
- Microwave
- Embolization
- Guidewires
- Global Interventional Oncology Market by Procedure, (USD Million)
- Thermal
- Non-Thermal Ablation
- TACE
- TARE
- TAE
- Global Interventional Oncology Market by Cancer, (USD Million)
- Liver
- Lung
- Kidney
- Bone Metastasis
- Global Interventional Oncology Market by End User, (USD Million)
- Hospital
- ASC
- Global Interventional Oncology Market by Region, (USD Million)
- Introduction
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
-
- Medtronic
- Boston Scientific
- Terumo
- Merit Medical
- Angio Dynamics
- J&J
- Teleflex
- Cook Medical
- HealthTronics
- MedWaves
*The Company List Is Indicative
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â US INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â US INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â US INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â US INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â CANADA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â CANADA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â CANADA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â CANADA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â MEXICO INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â MEXICO INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â MEXICO INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â MEXICO INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â BRAZIL INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â ARGENTINA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â COLOMBIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â REST OF SOUTH AMERICA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â INDIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â INDIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â INDIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â INDIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â CHINA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â CHINA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â CHINA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â CHINA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â JAPAN INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â JAPAN INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â JAPAN INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â JAPAN INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â SOUTH-EAST ASIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â REST OF ASIA PACIFIC INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â GERMANY INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â GERMANY INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â GERMANY INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â GERMANY INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â UK INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â UK INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â UK INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â UK INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â FRANCE INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â FRANCE INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â FRANCE INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â FRANCE INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â ITALY INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â ITALY INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â ITALY INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â ITALY INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â SPAIN INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â SPAIN INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â SPAIN INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 80Â Â Â Â Â Â Â SPAIN INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 81Â Â Â Â Â Â Â RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 82Â Â Â Â Â Â Â RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 83Â Â Â Â Â Â Â RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 84Â Â Â Â Â Â Â RUSSIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 85Â Â Â Â Â Â Â REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 86Â Â Â Â Â Â Â REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 87Â Â Â Â Â Â Â REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 88Â Â Â Â Â Â Â REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 89Â Â Â Â Â Â Â UAE INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 90Â Â Â Â Â Â Â UAE INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 91Â Â Â Â Â Â Â UAE INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 92Â Â Â Â Â Â Â UAE INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 93Â Â Â Â Â Â Â SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 94Â Â Â Â Â Â Â SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 95Â Â Â Â Â Â Â SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 96Â Â Â Â Â Â Â SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 97Â Â Â Â Â Â Â SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 98Â Â Â Â Â Â Â SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 99Â Â Â Â Â Â Â SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 100Â Â Â Â Â SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
TABLE 101Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 102Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 103Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 104Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL ONCOLOGY MARKET BY CANCER (USD MILLIONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE, USD MILLION, 2019-2028
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY END USER, USD MILLION, 2019-2028
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT, USD MILLION, 2019-2028
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY CANCER, USD MILLION, 2019-2028
FIGURE 12Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY REGION, USD MILLION, 2019-2028
FIGURE 13          PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PROCEDURE, 2020
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY END USER 2020
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY PRODUCT 2020
FIGURE 17Â Â Â Â Â Â Â Â Â Â GLOBAL INTERVENTIONAL ONCOLOGY MARKET BY CANCER 2020
FIGURE 18Â Â Â Â Â Â Â Â Â Â INTERVENTIONAL ONCOLOGY MARKET BY REGION 2020
FIGURE 19Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 20Â Â Â Â Â Â Â Â Â Â MEDTRONIC: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â BOSTON SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â TERUMO: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â MERIT MEDICAL: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â ANGIO DYNAMICS: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â J&J: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â TELEFLEX: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â COOK MEDICAL: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â HEALTHTRONICS: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â MEDWAVES: COMPANY SNAPSHOT
FAQ
The Interventional Oncology market size had crossed USD 1.9 billion in 2020 and will observe a CAGR of more than % up to 2029 driven by the rising technological advancements.
North America held more than 35% of the Interventional Oncology market revenue share in 2021 and will witness expansion. In 2020, the worldwide interventional oncology market was headed by Boston Scientific (US). To expand its market presence and product offerings, the firm primarily relies on growth techniques such as acquisitions and expansions. The company’s acquisition of BTG will help it grow its chemoembolization, radioembolization, and ablation therapy options. Boston Scientific seeks to get regulatory and reimbursement approvals on a regular basis. By increasing its position in the global healthcare sector, the firm invests in fast-growing areas as well as new markets as part of its long-term growth plan.
One of the drivers of interventional oncology is rising patient preference for minimally invasive procedures. One of the restraints of the interventional oncology market is the dearth of well trained and skilled radiologists and oncologists. One of the biggest opportunities in the interventional oncology market are the emerging economies which offer high growth potential.
North America, followed by Europe, was the largest regional component of the entire market in 2020. The high incidence of chronic illnesses, expanding geriatric population, increasing use of minimally invasive treatments, and the presence of significant companies in the region all contribute to the region’s big market share.
With a CAGR of 9.6% over the projection period, Asia Pacific is the fastest-growing regional category in the interventional oncology market. The APAC interventional oncology market is growing due to rising healthcare expenditure, an increase in the number of hospitals and CROs in India and China, an expanding research base in India, China, and Japan, government efforts to increase funding, and supportive regulations for the development and commercialization of advanced interventional oncology products.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.